In some patients, COVID-19 can trigger neurological symptoms with unclear pathogenesis.
Here we describe a microphysiological system integrating alveolus and blood–brain barrier …

Cerebrovascular events have emerged as a central feature of the clinical syndrome
associated with Sars-CoV-2 infection. This increase in infection-related strokes is marked by …

Worldwide, over 694 million people have been infected with SARS-CoV-2, with an estimated
55–60% of those infected developing COVID-19. Since the beginning of the pandemic in …

Ever since it was first reported in Wuhan, China, the coronavirus-induced disease of 2019
(COVID-19) has become an enigma of sorts with ever expanding reports of direct and …

A wide range of neurological manifestations have been associated with the development of
COVID-19 following SARS-CoV-2 infection. However, the etiology of the neurological …

The spectrum of health complications instigated by coronavirus disease 2019 (COVID-19,
caused by the novel severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2) …

Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic. Although COVID-19 …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of
coronavirus disease 2019 (COVID-19), can induce a plethora of neurological complications …

Abstract Background SARS-CoV-2, a coronavirus (CoV), is known to cause acute respiratory
distress syndrome, and a number of non-respiratory complications, particularly in older male …

Though COVID-19 is primarily characterized by symptoms in the periphery, it can also affect
the central nervous system (CNS). This has been established by the association between …